Renalytix AI Insiders

Renalytix employs about 9 people. The company is managed by 9 executives with a total tenure of roughly 21 years, averaging almost 2.0 years of service per executive, having 1.0 employees per reported executive. Break down of Renalytix's management performance can provide insight into the company performance.
  
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.

Renalytix Management Team Effectiveness

The company has return on total asset (ROA) of (0.9354) % which means that it has lost $0.9354 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (10.7318) %, meaning that it created substantial loss on money invested by shareholders. Renalytix's management efficiency ratios could be used to measure how well Renalytix manages its routine affairs as well as how well it operates its assets and liabilities.

Renalytix Workforce Comparison

Renalytix AI is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 38,452. Renalytix adds roughly 9.0 in number of employees claiming only tiny portion of equities under Health Care industry.

Renalytix Insider Trading

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Renalytix insiders, such as employees or executives, is commonly permitted as long as it does not rely on Renalytix's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Renalytix insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Renalytix Notable Stakeholders

A Renalytix stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Renalytix often face trade-offs trying to please all of them. Renalytix's stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Renalytix's stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
Oliver IIIChief OfficerProfile
Jean CasnerVP OfficerProfile
Baljit SinghHead OperationsProfile
Howard DoranChief OfficerProfile
Salim FCACompany SecretaryProfile
Fergus FlemingChief OfficerProfile
Andria ParksHerreraVP MarketingProfile
Joel MBAInterim OfficerProfile
James MBAChief OfficerProfile

Renalytix Workforce Analysis

Traditionally, organizations such as Renalytix use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Renalytix within its industry.

Renalytix Manpower Efficiency

Return on Renalytix Manpower

Revenue Per Employee254.3K
Revenue Per Executive254.3K
Net Loss Per Employee3.7M
Net Loss Per Executive3.7M
Working Capital Per Employee1.4M
Working Capital Per Executive1.4M
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis.
You can also try the Options Analysis module to analyze and evaluate options and option chains as a potential hedge for your portfolios.

Other Consideration for investing in Renalytix Stock

If you are still planning to invest in Renalytix AI check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Renalytix's history and understand the potential risks before investing.
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments